ArticleNature communications2022
An intranasal ASO therapeutic targeting SARS-CoV-2.
Chi Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this papercites it
ArticleNature communications2022
Chi Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.